Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy and Bone Marrow Transplantation in Acute Non-Lymphocytic Leukemia
NCT00002547Phase 2Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Aug 1987
- Primary completion
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of busulfan, cyclophosphamide, cytarabine in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), sponsored by Barbara Ann Karmanos Cancer Institute. Started Aug 1987; status: completed.
02
Drugs
busulfancyclophosphamidecytarabine
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00002547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002547.